Remote assessment and artificial intelligence to validate new measures, biomarkers, and therapeutic targets for facioscapulohumeral muscular dystrophy (FSHD)
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common genetic muscular diseases (myopathies) in adults. Its name reflects the main muscles affected: the face (facio-), shoulders (scapulo-), and upper arms (humeral). (Source: Orphanet)
By combining all data collected from patients with FSHD and analyzing them through artificial intelligence, the team aims to create a database within the France Cohortes information system containing all the necessary clinical and biological information.
This resource will enable the development and validation of new digital measures that can be used in clinical trials and real-world studies, as well as the identification of serum biomarkers and innovative therapeutic strategies.
Scientific and Technical Lead:
Prof. Sabrina SACCONI, Head of the "Peripheral Nervous System, Muscle" unit, Reference Center for Neuromuscular Diseases, Neurosciences/Rheumatology Department, Nice University Hospital.
